Daily Trades
- Dylan Jovine
Yesterday, President Trump took the oath of office for a second time.
- Dylan Jovine
Takeover activity is set to boom over the next four years.
- Dylan Jovine
Let me start this week with a quick update on Iovance Biotherapeutics (SYM: IOVA).
- Dylan Jovine
I know a lot of you bought Iovance Biotherapeutics (SYM: IOVA) on my recommendation, and the stock is down.
- Dylan Jovine
This climate of fear is our friend. It has created opportunities in the biotech sector which will look downright silly in three to five years.
- Dylan Jovine
I’d like to re-recommend one of our old favorites, Tower Semiconductor (SYM: TSEM) here at $46.37.
- Dylan Jovine
I wanted to share my take on Iovance’s (SYM: IOVA) second quarter earnings now...
- Dylan Jovine
Shares jumped 44% this week after the company reported its first full quarter after winning FDA approval for its T-cell melanoma therapy Amtavi (lifecel).
- Dylan Jovine
I start this week with a quote -
“It was the best of times, it was the worst of times, it was the age of wisdom, it was the age of foolishness, it was the epoch of belief, it was the epoch of incredulity, it was the season of light, it was the season of darkness, it was the spring of hope, it was the winter of despair.”
- Dylan Jovine
I have a simple cash skim for you today: HashiCorp (SYM: HCP) here at $32.50.
deal of the month
Categories
Dylan Jovine | Trump’s $1 Trillion Defense Budget Creates Massive Investment Boom
Dylan Jovine | Bull? Bear? Nobody Knows. China Tariffs Spark Volatility and Wall Street Confusion
Dylan Jovine | US Debt Crisis 2025: Why Creditors Are Dumping Treasuries
Recent posts
Tags
Connect with Us
- Dylan Jovine
Yesterday, President Trump took the oath of office for a second time.
- Dylan Jovine
Takeover activity is set to boom over the next four years.
- Dylan Jovine
Let me start this week with a quick update on Iovance Biotherapeutics (SYM: IOVA).
- Dylan Jovine
I know a lot of you bought Iovance Biotherapeutics (SYM: IOVA) on my recommendation, and the stock is down.
- Dylan Jovine
This climate of fear is our friend. It has created opportunities in the biotech sector which will look downright silly in three to five years.
- Dylan Jovine
I’d like to re-recommend one of our old favorites, Tower Semiconductor (SYM: TSEM) here at $46.37.
- Dylan Jovine
I wanted to share my take on Iovance’s (SYM: IOVA) second quarter earnings now...
- Dylan Jovine
Shares jumped 44% this week after the company reported its first full quarter after winning FDA approval for its T-cell melanoma therapy Amtavi (lifecel).
- Dylan Jovine
I start this week with a quote -
“It was the best of times, it was the worst of times, it was the age of wisdom, it was the age of foolishness, it was the epoch of belief, it was the epoch of incredulity, it was the season of light, it was the season of darkness, it was the spring of hope, it was the winter of despair.”
- Dylan Jovine
I have a simple cash skim for you today: HashiCorp (SYM: HCP) here at $32.50.
Get FREE Daily Stock Tips
Join and receive market insider stock picks, trade alerts and unique investing insights
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.